Indeed, mice with Treg cell-specific inactivation of p110δ or those treated with a p110δ-specific inhibitor show increased anti-tumor immunity [135, 136], further illustrating the metabolic “Goldilocks” effect for Treg cell function [69]. The gene discussed is PIK3CD; the disease is neoplasm.